» Articles » PMID: 3352273

Chordoma: Natural History and Treatment Results in 33 Cases

Overview
Journal J Surg Oncol
Date 1988 Mar 1
PMID 3352273
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty-three chordomas were observed at the Istituto Nazionale Tumori of Milan from 1933 to 1983: 27 sacrococcygeal, 3 spheno-occipital, and 3 vertebral. The male:female ratio was 2.7, and the median age was 63 yr for patients with sacrococcygeal and 35.2 yr for those with nonsacral chordomas. After pathologic reassessment, distinct cytologic patterns were found: physaliphorous, syncytial, and mixed subtypes, with variable degrees of cytologic atypia. However, no evident difference in survival was documented in relation to these cytohistologic features. Four cases had a prior traumatic fracture, and the pathogenetic role of trauma is stressed. Eight cases were operated with adequate surgery and only three recurred, whereas of 11 inadequate operations, 10 developed local relapse. However, follow-up for recent adequate operations is short. Radiation therapy seemed to be effective with adjuvant or palliative aims. No chemotherapeutic regimen achieved any result; one case had a short complete remission after cis-dichlorodiammineplatinum + vinblastine + bleomycin (PVB). This analysis confirms the possibility of achieving radicality with high resection of the sacrum for lesions confined below the second sacral vertebra. Nonsacral chordomas were all unresectable. The best treatment for unresectable lesions seems to be palliative surgery plus radiotherapy.

Citing Articles

Surgical management of skull base and spinal chordomas: A case series with comprehensive review of the literature.

Lee S, Teferi N, Vivanco-Suarez J, Chowdhury A, Glennon S, Kato K N Am Spine Soc J. 2024; 20:100569.

PMID: 39687058 PMC: 11648787. DOI: 10.1016/j.xnsj.2024.100569.


The novel developed and validated multiparametric MRI-based fusion radiomic and clinicoradiomic models predict the postoperative progression of primary skull base chordoma.

Li Z, Fan Y, Ma J, Wang K, Li D, Zhang J Sci Rep. 2024; 14(1):28752.

PMID: 39567620 PMC: 11579367. DOI: 10.1038/s41598-024-80410-5.


Immunologic and Targeted Molecular Therapies for Chordomas: A Narrative Review.

Golding R, Abuqubo R, Pansa C, Bhatta M, Shankar V, Mani K J Clin Med. 2024; 13(19).

PMID: 39407739 PMC: 11476405. DOI: 10.3390/jcm13195679.


Spinal chordoma and chondrosarcoma treatment experiences - a 20-year retrospective study from databases of two medical centers.

Kuo P, Yeh Y, Chang K, Tsai T, Lai P, Tsuang F Sci Rep. 2024; 14(1):23012.

PMID: 39362937 PMC: 11450190. DOI: 10.1038/s41598-024-74317-4.


Exceptionally giant neglected sacral chordoma in a post-poliotic residual paralysis patient - a rare case scenario.

Kantiwal P, Aggarwal A, Yadav S, Gahlot N, Elhence A Am J Neurodegener Dis. 2024; 13(3):13-22.

PMID: 39308697 PMC: 11411203. DOI: 10.62347/EKNJ6411.